Press releases
EMA recommends temporary suspension of EQL Pharma drug, with reduced earnings for 2017 as a result
2017-04-03 The European Medicines Agency recommends a temporary withdrawal of a number of drugs for which bioequivalence studies has been conducted at Micro Therapeutic Research Labs, India.
Press Release 2017-04-03
-
2017-07-05Positive news concerning the pharmaceutical product Eletriptan EQL Pharma
The pharmaceutical product Eletriptan EQL Pharma was approved Monday within the framework…
-
2017-07-03Zonisamid EQL Pharma launched in Denmark
Zonisamide EQL Pharma is an antiepileptic, used for the treatment of epilepsy.…
-
2017-05-17Report from the Annual General Meeting of EQL Pharma AB (publ) on May 15th, 2017
Adoption of the balance sheet and income statement, disposition regarding the Company’s…
-
2017-05-09Positive news concerning the pharmaceutical product Kaliumklorid EQL Pharma
The pharmaceutical product Kaliumklorid EQL Pharma (potassium chloride tablets) has today been…
-
2017-01-23The Nomination Committee for the Annual General Meeting in 2017
2017-01-23 In accordance with a resolution from the 2016 Annual General Meeting…
-
2016-11-16EQL Pharma strengthens its organization with Alexander Brising, New Business Development Director
EQL Pharma has recruited Alexander Brising as head of business development at…
-
2016-10-10Zonisamid EQL Pharma now approved in Denmark
The medical product Zonisamid EQL Pharma has now been approved for sale…
-
2016-01-21The Nomination Committee for the Annual General Meeting in 2016
In accordance with a resolution from the 2015 Annual General Meeting the…
-
2015-09-23EQL Pharma enters into a strategic agreement with Cadila Pharmaceuticals Limited
EQL Pharma AB has today, entered into a strategic agreement with Cadila…
-
2015-04-17EQL Pharma’s 2014 Annual Report now available
Today, EQL Pharma announced that the company’s Annual Report for 2014 is…